Session topics
The Minerva Foundation Symposium 2025 is organized by the Minerva Foundation – a private institution dedicated to advancing medical and bioscience research in Finland.
Thursday 23 October
- Steatotic liver disease – Leveraging genetics for therapeutic insights
- Incretins – Bench to bedside
Friday 24 October
- Bone and mineral metabolism, its genetic components and therapeutic approaches
- Genetics and pharmacogenetics in personalized medicine
- Panel Discussion – Emerging new therapies: The path from innovation to cost-effective benefit to the patients
Network and learn from groundbreaking research
The Minerva Foundation Symposium 2025 gathers leading experts in medical research to discuss the latest advancements in research to understand and treat various diseases. Over two days, researchers from around the world will share their insights on how genetic discoveries can be transformed into therapeutic approaches and clinical applications.
The event is open to researchers, academics, doctors, and other professionals in medical research and related fields, as well as the general public. We also welcome students and anyone interested in the latest developments in genetic research and its applications in clinical medicine.
According to the University of Helsinki decision UH254185, participants may apply for the following number of hours to be accredited towards specialist training: Endocrinology – 8 hours; Gastroenterology – 3 hours; Nephrology – 1 hour; Medical Genetics – 5 hours; Internal Medicine – 10 hours.
The event is free of charge.
Symposium speakers 2025
Panu Luukkonen,
Minerva Foundation Institute for medical Research – FI
Russell Goodman,
Harvard/Massachusetts General Hospital – US
Outi Mäkitie,
Folkhälsan, University of Helsinki and Helsinki University Hospital – FI
Shawn Burgess,
UT Southwestern – US
Sami Qadri,
Minerva Foundation Institute for medical Research – FI
Petter Bjornstad,
University of Washington, Seattle – US
David Cherney,
University of Toronto – CA
Ian de Boer,
University of Washington, Seattle, – US
Wim van Hul,
University of Antwerp – BE
Harald Jüppner,
Massachusetts General Hospital, Harvard Medical School, Boston– US
Vilma Lammi,
FIMM, University of Helsinki and Broad Institute of MIT and Harvard, Cambridge, MA – US
Heikki Koistinen,
Minerva Foundation Institute for Medical Research – FI
Adrian R. Krainer,
St. Giles Foundation, Cancer Center Program Co-Leader – US
Elisabeth Widen,
FIMM, University of Helsinki – FI
Mikko Niemi,
University of Helsinki – FI
Sami Pakarinen
-
About the Symposium
The Minerva Foundation Symposium 2025 is organized by the Minerva Foundation – a private institution dedicated to advancing medical and bioscience research in Finland. The Foundation supports cutting-edge scientific studies and fosters international collaboration to enhance understanding and treatment of various diseases. This symposium serves as a platform for sharing the latest research insights and promoting dialogue among leading experts in the field.
The symposium is entirely independent, and financed by the Minerva Foundation.
